Citations

Citations to this article as recorded by  

• Steroid administration for post‐COVID‐19 Parkinsonism: A case report
  Witoon Mitarnun, Metha Apiwattanakul, Thanatchanan Thodthasri, Praewa Tantisungvarakoon, Wilasinee Pangwong
  Neurology and Clinical Neuroscience.2023; 11(1): 49.     CrossRef
• Parkinson’s Disease in Light of the COVID-19 Pandemic
  Anna Drelich-Zbroja, Mateusz Cheda, Maryla Kuczyńska, Izabela Dąbrowska, Ewa Kopyto, Izabela Halczuk
  Brain Sciences.2022; 12(2): 143.     CrossRef
• Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review
  Jeremy M. Morowitz, Kaylyn B. Pogson, Daniel A. Roque, Frank C. Church
  Brain Sciences.2022; 12(5): 536.     CrossRef
• Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far
  Iro Boura, Kallol Ray Chaudhuri
  Movement Disorders Clinical Practice.2022; 9(5): 584.     CrossRef
• COVID-19 and Parkinsonism: A Critical Appraisal
  Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, Eleonora Del Prete, Sara Meoni, Sara Grisanti, Marialuisa Zedde, Rosario Pascarella, Elena Moro, Franco Valzania
  Biomolecules.2022; 12(7): 970.     CrossRef
• Viruses, parkinsonism and Parkinson’s disease: the past, present and future
  Valentina Leta, Daniele Urso, Lucia Batzu, Yue Hui Lau, Donna Mathew, Iro Boura, Vanessa Raeder, Cristian Falup-Pecurariu, Daniel van Wamelen, K. Ray Chaudhuri
  Journal of Neural Transmission.2022; 129(9): 1119.     CrossRef
• Movement Disorders and SARS‐CoV ‐2
  Wilson K.W. Fung, Alfonso Fasano, Conor Fearon
  Movement Disorders Clinical Practice.2022;[Epub]     CrossRef